Search - tctmd.com

Displaying 881 - 900 of 1761

Sort: Relevancy | Date

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Daily News

Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart

Michael O'Riordan

January 07, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Speeding Cardiologists in Florida Most Likely to Drive ‘Luxury’ Cars

Michael O'Riordan

December 25, 2019

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

Taggart Rebuts EXCEL Response, Insisting on Retraction

News Daily News

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

Michael O'Riordan

December 18, 2019

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Daily News

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

Michael O'Riordan

December 16, 2019

News Daily News

FDA Approves Icosapent Ethyl for Reducing CVD Events

Michael O'Riordan

December 13, 2019

News Features

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Michael O'Riordan

December 12, 2019

News Daily News

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

Michael O'Riordan

December 10, 2019

News Daily News

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Michael O'Riordan

December 10, 2019

Advertisement

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Speeding Cardiologists in Florida Most Likely to Drive ‘Luxury’ Cars

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

FDA Approves Icosapent Ethyl for Reducing CVD Events

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Poor Exercise Capacity on Stress Echo in Women Predicts Death From CVD

EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content